ID   MGAT2_HUMAN             Reviewed;         447 AA.
AC   Q10469; B3KPC5; B3KQM0;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   10-MAY-2017, entry version 163.
DE   RecName: Full=Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase;
DE            EC=2.4.1.143;
DE   AltName: Full=Beta-1,2-N-acetylglucosaminyltransferase II;
DE   AltName: Full=GlcNAc-T II;
DE            Short=GNT-II;
DE   AltName: Full=Mannoside acetylglucosaminyltransferase 2;
DE   AltName: Full=N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II;
GN   Name=MGAT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 1-16.
RC   TISSUE=Leukocyte;
RX   PubMed=7635144; DOI=10.1111/j.1432-1033.1995.tb20703.x;
RA   Tan J., D'Agostaro A.F., Bendiak B., Reck F., Sarkar M., Squire J.A.,
RA   Leong P., Schachter H.;
RT   "The human UDP-N-acetylglucosamine: alpha-6-D-mannoside-beta-1,2-N-
RT   acetylglucosaminyltransferase II gene (MGAT2). Cloning of genomic DNA,
RT   localization to chromosome 14q21, expression in insect cells and
RT   purification of the recombinant protein.";
RL   Eur. J. Biochem. 231:317-328(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANTS CDG2A ARG-262 AND PHE-290.
RX   PubMed=8808595;
RA   Tan J., Dunn J., Jaeken J., Schachter H.;
RT   "Mutations in the MGAT2 gene controlling complex N-glycan synthesis
RT   cause carbohydrate-deficient glycoprotein syndrome type II, an
RT   autosomal recessive disease with defective brain development.";
RL   Am. J. Hum. Genet. 59:810-817(1996).
RN   [6]
RP   VARIANT CDG2A ASP-318.
RX   PubMed=11228641; DOI=10.1136/jmg.37.11.875;
RA   Cormier-Daire V., Amiel J., Vuillaumier-Barrot S., Tan J., Durand G.,
RA   Munnich A., Le Merrer M., Seta N.;
RT   "Congenital disorders of glycosylation IIa cause growth retardation,
RT   mental retardation, and facial dysmorphism.";
RL   J. Med. Genet. 37:875-877(2000).
CC   -!- FUNCTION: Catalyzes an essential step in the conversion of oligo-
CC       mannose to complex N-glycans.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-D-glucosamine + 6-(alpha-D-
CC       mannosyl)-beta-D-mannosyl-R = UDP + 6-(2-(N-acetyl-beta-D-
CC       glucosaminyl)-alpha-D-mannosyl)-beta-D-mannosyl-R.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane; Single-pass type
CC       II membrane protein.
CC   -!- DISEASE: Congenital disorder of glycosylation 2A (CDG2A)
CC       [MIM:212066]: A multisystem disorder caused by a defect in
CC       glycoprotein biosynthesis and characterized by under-glycosylated
CC       serum glycoproteins. Congenital disorders of glycosylation result
CC       in a wide variety of clinical features, such as defects in the
CC       nervous system development, psychomotor retardation, dysmorphic
CC       features, hypotonia, coagulation disorders, and immunodeficiency.
CC       The broad spectrum of features reflects the critical role of N-
CC       glycoproteins during embryonic development, differentiation, and
CC       maintenance of cell functions. {ECO:0000269|PubMed:11228641,
CC       ECO:0000269|PubMed:8808595}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 16 (GT16) protein
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Alpha-1,6-mannosyl-glycoprotein 2-beta-N-
CC       acetylglucosaminyltransferase;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_534";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U15128; AAA86956.1; -; Genomic_DNA.
DR   EMBL; AK056167; BAG51637.1; -; mRNA.
DR   EMBL; AK075199; BAG52082.1; -; mRNA.
DR   EMBL; CH471078; EAW65758.1; -; Genomic_DNA.
DR   EMBL; BC006390; AAH06390.1; -; mRNA.
DR   CCDS; CCDS9690.1; -.
DR   PIR; S66256; S66256.
DR   RefSeq; NP_002399.1; NM_002408.3.
DR   UniGene; Hs.93338; -.
DR   ProteinModelPortal; Q10469; -.
DR   BioGrid; 110403; 2.
DR   STRING; 9606.ENSP00000307423; -.
DR   BindingDB; Q10469; -.
DR   ChEMBL; CHEMBL2321630; -.
DR   CAZy; GT16; Glycosyltransferase Family 16.
DR   iPTMnet; Q10469; -.
DR   PhosphoSitePlus; Q10469; -.
DR   BioMuta; MGAT2; -.
DR   DMDM; 1708004; -.
DR   EPD; Q10469; -.
DR   MaxQB; Q10469; -.
DR   PaxDb; Q10469; -.
DR   PeptideAtlas; Q10469; -.
DR   PRIDE; Q10469; -.
DR   DNASU; 4247; -.
DR   Ensembl; ENST00000305386; ENSP00000307423; ENSG00000168282.
DR   GeneID; 4247; -.
DR   KEGG; hsa:4247; -.
DR   UCSC; uc001wwr.4; human.
DR   CTD; 4247; -.
DR   DisGeNET; 4247; -.
DR   GeneCards; MGAT2; -.
DR   GeneReviews; MGAT2; -.
DR   H-InvDB; HIX0211283; -.
DR   HGNC; HGNC:7045; MGAT2.
DR   HPA; HPA043721; -.
DR   HPA; HPA056824; -.
DR   MalaCards; MGAT2; -.
DR   MIM; 212066; phenotype.
DR   MIM; 602616; gene.
DR   neXtProt; NX_Q10469; -.
DR   OpenTargets; ENSG00000168282; -.
DR   Orphanet; 79329; MGAT2-CDG.
DR   PharmGKB; PA30780; -.
DR   eggNOG; KOG2791; Eukaryota.
DR   eggNOG; ENOG410XPYF; LUCA.
DR   GeneTree; ENSGT00390000007341; -.
DR   HOVERGEN; HBG052467; -.
DR   InParanoid; Q10469; -.
DR   KO; K00736; -.
DR   OMA; TRNAYQK; -.
DR   OrthoDB; EOG091G05U3; -.
DR   PhylomeDB; Q10469; -.
DR   TreeFam; TF314772; -.
DR   BioCyc; MetaCyc:HS09725-MONOMER; -.
DR   Reactome; R-HSA-975578; Reactions specific to the complex N-glycan synthesis pathway.
DR   UniPathway; UPA00378; -.
DR   GeneWiki; MGAT2; -.
DR   GenomeRNAi; 4247; -.
DR   PRO; PR:Q10469; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000168282; -.
DR   CleanEx; HS_MGAT2; -.
DR   Genevisible; Q10469; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005795; C:Golgi stack; IEA:InterPro.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008455; F:alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; TAS:Reactome.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:Ensembl.
DR   GO; GO:0009312; P:oligosaccharide biosynthetic process; IEA:InterPro.
DR   GO; GO:0009311; P:oligosaccharide metabolic process; TAS:ProtInc.
DR   GO; GO:0006487; P:protein N-linked glycosylation; TAS:ProtInc.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IEA:Ensembl.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR007754; GlcNAc_II.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR12871; PTHR12871; 1.
DR   Pfam; PF05060; MGAT2; 1.
DR   SUPFAM; SSF53448; SSF53448; 2.
PE   1: Evidence at protein level;
KW   Complete proteome; Congenital disorder of glycosylation;
KW   Direct protein sequencing; Disease mutation; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Membrane; Reference proteome;
KW   Signal-anchor; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    447       Alpha-1,6-mannosyl-glycoprotein 2-beta-N-
FT                                acetylglucosaminyltransferase.
FT                                /FTId=PRO_0000080517.
FT   TOPO_DOM      1      9       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     10     29       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     30    447       Lumenal. {ECO:0000255}.
FT   CARBOHYD     69     69       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     86     86       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     262    262       H -> R (in CDG2A; dbSNP:rs104894447).
FT                                {ECO:0000269|PubMed:8808595}.
FT                                /FTId=VAR_003415.
FT   VARIANT     290    290       S -> F (in CDG2A; dbSNP:rs104894446).
FT                                {ECO:0000269|PubMed:8808595}.
FT                                /FTId=VAR_003416.
FT   VARIANT     318    318       N -> D (in CDG2A; dbSNP:rs104894448).
FT                                {ECO:0000269|PubMed:11228641}.
FT                                /FTId=VAR_012343.
FT   CONFLICT    299    299       S -> R (in Ref. 2; BAG52082).
FT                                {ECO:0000305}.
SQ   SEQUENCE   447 AA;  51550 MW;  533B76D08BD8A572 CRC64;
     MRFRIYKRKV LILTLVVAAC GFVLWSSNGR QRKNEALAPP LLDAEPARGA GGRGGDHPSV
     AVGIRRVSNV SAASLVPAVP QPEADNLTLR YRSLVYQLNF DQTLRNVDKA GTWAPRELVL
     VVQVHNRPEY LRLLLDSLRK AQGIDNVLVI FSHDFWSTEI NQLIAGVNFC PVLQVFFPFS
     IQLYPNEFPG SDPRDCPRDL PKNAALKLGC INAEYPDSFG HYREAKFSQT KHHWWWKLHF
     VWERVKILRD YAGLILFLEE DHYLAPDFYH VFKKMWKLKQ QECPECDVLS LGTYSASRSF
     YGMADKVDVK TWKSTEHNMG LALTRNAYQK LIECTDTFCT YDDYNWDWTL QYLTVSCLPK
     FWKVLVPQIP RIFHAGDCGM HHKKTCRPST QSAQIESLLN NNKQYMFPET LTISEKFTVV
     AISPPRKNGG WGDIRDHELC KSYRRLQ
//
